Please provide your email address to receive an email when new articles are posted on . American Society for Radiation Oncology issued its first clinical guideline for sarcoma. The guideline — ...
Survival and Failure Patterns of High-Grade Gliomas After Three-Dimensional Conformal Radiotherapy PURPOSE: Adjuvant radiation therapy (RT) has been shown to improve local control in patients with ...
Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparable tumor ...
Patients in this analysis were treated between 2007 and 2020 and could have received radiotherapy either before or after surgery for soft tissue sarcoma (STS). STS is rare, in that it accounts for a ...
Five-day course of preoperative radiation therapy for sarcoma provides excellent local control rates
In a phase 2 single-institution study, UCLA Jonsson Comprehensive Cancer Center researchers found that dose-equivalent preoperative radiation therapy for extremity/trunk soft tissue sarcoma delivered ...
Activity of crizotinib (C) in patients (pts) with clear cell sarcoma (CCSA) in EORTC phase II trial 90101 "CREATE". This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...
In patients with mostly undifferentiated pleomorphic sarcomas, 2-year DFS with the addition of preoperative and postoperative pembrolizumab (Keytruda) infusions reached 67%, as compared with 52% with ...
According to new research, radiation therapy administered before surgery rarely produces favorable responses in patients with ...
Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma. Noting that immunotherapy for soft tissue sarcoma (STS) has ...
Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...
Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback